The role of IL-33 signaling in the pathophysiology of preeclampsia
IL-33信号在先兆子痫病理生理学中的作用
基本信息
- 批准号:10744187
- 负责人:
- 金额:$ 3.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-15 至 2024-08-14
- 项目状态:已结题
- 来源:
- 关键词:AffectArteriesAttenuatedBiological AvailabilityBlood PressureBlood VesselsCellsCharacteristicsChildClinical DataClinical ResearchComplexDataDevelopmentDiseaseEtiologyExhibitsFetal Growth RetardationFetal Mortality StatisticsFetal WeightFetal healthFunctional disorderHuman CharacteristicsHypertensionImmuneImmune responseImpairmentIn VitroInflammasomeInflammationInflammatoryInfusion proceduresIschemiaLinkMaternal HealthMaternal MortalityMediatingModelingNK Cell ActivationNatural Killer CellsOrganOxidative StressPerfusionPlacentaPlasmaPopulationPre-EclampsiaPregnancyPrevalenceProcessPublishingRattusReceptor InhibitionRecombinantsResearchRiskRoleSignal PathwaySignal TransductionSpiral Artery of the EndometriumSupplementationTechniquesTestingUnited StatesUterusVascular DiseasesVascular resistanceWomanWomen&aposs Healthcell typeeffective therapyfetalimprovedin vivokidney vascular structurematernal hypertensionmaternal morbidityneutralizing antibodynew therapeutic targetnovelpathophysiology of preeclampsiapregnantpressureresponsetheoriestherapeutic target
项目摘要
Project Summary/Abstract
Preeclampsia (PE) is a pregnancy specific disorder characterized by the development of hypertension in
combination with end-organ dysfunction after 20 weeks of gestation. The prevalence of this disorder has
continuously increased over the past 20 years and it is a leading cause of fetal and maternal morbidity. Despite
the burden PE causes on maternal and fetal health, no effective treatment for PE exists other than delivery of
the fetal-placental unit and there is an urgent need to understand PE pathophysiology in order to identify potential
therapeutic targets. It is known that altered immune responses contribute to PE pathophysiology. However, the
mechanisms underlying and contributing to those altered responses are not well understood though clinical
studies have identified elevated activation of the NLRP3 inflammasome as a potential contributor to altered
immune responses. The Reduced Uterine Perfusion Pressure (RUPP) model of placental ischemia, which our
lab uses, is a widely acknowledged model and recapitulates many characteristics of human PE. Using this model,
our preliminary data shows NLRP3 mediates increases in maternal blood pressure, intrauterine growth
restriction, and TH17 and cytolytic NK (cNK) cell activation in RUPP rats. This is consistent with studies on NLRP3
activation in other inflammatory disease processes, which also show increased NLRP3 activation causing
increased TH17 and cNK cell activation. Previous studies propose NLRP3 activation achieves TH17 and cNK cell
activation through inhibition of IL-33 signaling, a signaling pathway known to inhibit TH17 and cNK cell activation.
Our preliminary data links aberrant IL-33 signaling to NLRP3 activation and shows supplementation of IL-33 in
RUPP rats results in lower maternal blood pressure, improved intrauterine growth restriction, and decreased
activation of TH17 and cytolytic NK cells. This data supports the ideas detailed in this proposal. The central
hypothesis behind this proposal is placental ischemia induced NLRP3 activation impairs IL-33 signaling to induce
TH17 and cNK cell activation leading to inflammation and oxidative stress to cause vascular dysfunction and the
development of maternal hypertension and intrauterine growth restriction. This hypothesis will be tested through
the following specific aims using both in vivo and in vitro techniques. Specific aim 1: Test the hypothesis that
decreased IL-33 signaling mediates TH17 and cytolytic NK cell activation, inflammation, and oxidative stress
leading to vascular dysfunction, and the development of maternal hypertension and IUGR in response to
placenta ischemia. Specific aim 2: Test the hypothesis that blockade of IL-33 signaling in pregnant rats will
induce TH17 and cytolytic NK cell activation, inflammation, and oxidative stress leading to vascular dysfunction,
and the development of hypertension and IUGR.
项目总结/摘要
先兆子痫(PE)是一种妊娠特异性疾病,其特征是在妊娠期发生高血压,
妊娠20周后合并终末器官功能障碍。这种疾病的流行
在过去20年中,这一比例持续上升,是胎儿和产妇发病的主要原因。尽管
PE对母亲和胎儿健康造成的负担,除了分娩外,没有有效的PE治疗方法。
胎儿-胎盘单位,迫切需要了解PE的病理生理学,以确定潜在的
治疗目标已知改变的免疫应答有助于PE病理生理学。但
尽管临床上对这些改变的应答的潜在和促成机制还没有很好地理解,
研究已经鉴定了NLRP 3炎性体的升高的活化作为改变炎症的潜在贡献者。
免疫反应。胎盘缺血的子宫灌注压降低(RUPP)模型,我们
实验室用途,是一种广泛认可的模型,并概括了人类体育的许多特征。使用该模型,
我们的初步数据显示,NLRP 3介导母体血压升高,子宫内生长,
限制,以及TH 17和细胞溶解NK(cNK)细胞活化。这与NLRP 3的研究一致
在其他炎性疾病过程中也显示NLRP 3活化增加,
增加TH 17和cNK细胞活化。先前的研究表明NLRP 3激活实现TH 17和cNK细胞
通过抑制IL-33信号传导(已知抑制TH 17和cNK细胞活化的信号传导途径)来激活。
我们的初步数据将异常的IL-33信号传导与NLRP 3激活联系起来,并显示在正常人中补充IL-33,
RUPP大鼠导致母体血压降低,宫内生长受限改善,
TH 17和溶细胞NK细胞的活化。这些数据支持了本提案中详细阐述的想法。中央
该提议背后的假设是胎盘缺血诱导的NLRP 3活化损害IL-33信号传导以诱导
TH 17和cNK细胞活化导致炎症和氧化应激,从而引起血管功能障碍,
母体高血压和宫内生长受限的发展。这一假设将通过
使用体内和体外技术的以下具体目的。具体目标1:检验以下假设:
IL-33信号传导减少介导TH 17和细胞溶解性NK细胞活化、炎症和氧化应激
导致血管功能障碍,以及母体高血压和IUGR的发展,
胎盘缺血具体目的2:检验阻断妊娠大鼠中的IL-33信号传导将
诱导TH 17和溶细胞NK细胞活化、炎症和氧化应激,导致血管功能障碍,
以及高血压和IUGR的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xi Wang其他文献
Xi Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xi Wang', 18)}}的其他基金
The role of IL-33 signaling in the pathophysiology of preeclampsia
IL-33信号在先兆子痫病理生理学中的作用
- 批准号:
10537658 - 财政年份:2022
- 资助金额:
$ 3.98万 - 项目类别:
相似海外基金
Analysis of spatiotemporal involvement of retinoic acid in pharyngeal arch arteries
视黄酸对咽弓动脉的时空影响分析
- 批准号:
22KJ2601 - 财政年份:2023
- 资助金额:
$ 3.98万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Molecular identification of the oxygen sensor(s) in the fetal ductus arteriosus and pulmonary artery: an integrated multiomic comparison of mitochondria in vital fetal arteries with opposing oxygen responses
胎儿动脉导管和肺动脉中氧传感器的分子识别:对胎儿重要动脉中具有相反氧反应的线粒体进行综合多组学比较
- 批准号:
462691 - 财政年份:2022
- 资助金额:
$ 3.98万 - 项目类别:
Operating Grants
Understanding the regulatory control of complex blood flow in conduit arteries and veins
了解导管动脉和静脉中复杂血流的调节控制
- 批准号:
RGPIN-2021-02563 - 财政年份:2022
- 资助金额:
$ 3.98万 - 项目类别:
Discovery Grants Program - Individual
Fetal cerebral arteries and prenatal alcohol exposure
胎儿脑动脉和产前酒精暴露
- 批准号:
10337722 - 财政年份:2022
- 资助金额:
$ 3.98万 - 项目类别:
Fetal cerebral arteries and prenatal alcohol exposure
胎儿脑动脉和产前酒精暴露
- 批准号:
10590708 - 财政年份:2022
- 资助金额:
$ 3.98万 - 项目类别:
Pregnenolone constricts cerebral vascular arteries through the direct modulation of BK ion channels
孕烯醇酮通过直接调节 BK 离子通道收缩脑血管动脉
- 批准号:
10441131 - 财政年份:2021
- 资助金额:
$ 3.98万 - 项目类别:
Understanding the regulatory control of complex blood flow in conduit arteries and veins
了解导管动脉和静脉中复杂血流的调节控制
- 批准号:
DGECR-2021-00028 - 财政年份:2021
- 资助金额:
$ 3.98万 - 项目类别:
Discovery Launch Supplement
Association of brain temperature increase and cerebrospinal fluid dynamics in chronic brain ischemia due to main trunk occlusion of cerebral arteries
脑动脉主干闭塞所致慢性脑缺血脑温度升高与脑脊液动力学的关系
- 批准号:
21K09108 - 财政年份:2021
- 资助金额:
$ 3.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studying guinea pig development to discover how natural collateral arteries form
研究豚鼠的发育以发现自然侧支动脉是如何形成的
- 批准号:
10195510 - 财政年份:2021
- 资助金额:
$ 3.98万 - 项目类别:
Studying guinea pig development to discover how natural collateral arteries form
研究豚鼠的发育以发现自然侧支动脉是如何形成的
- 批准号:
10405492 - 财政年份:2021
- 资助金额:
$ 3.98万 - 项目类别: